fangdisun· @fangdisun · X·· 4 天前评分60
正文 · 机器翻译
#ESMO26 将于不到一周后开幕！以下是我对值得关注的 #HNcancer 研究的总结和评论，其中数项研究有助于进一步解读一线复发/转移性环境下正在开展的 III 期试验。‼️ 目前没有研究能立即改变美国的临床实践，但希望在未来 1–2 年看到更多数据。@OncBrothers @OncoAlert @myESMO @OncLive
热度 10 · 6 赞 · 0 回复 · 4 转发
会议摘要
NCT04943445NCT04943445按 - **标题 / Title：** Study of a Pembrolizumab-based Organ Preservation Strategy for Locally Advanced Larynx Cancers 对上
- **标题 / Title：** Study of a Pembrolizumab-based Organ Preservation Strategy for Locally Advanced Larynx Cancers读摘要原文 →NCT06295731NCT06295731按 - **标题 / Title：** INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC 对上
- **标题 / Title：** INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC读摘要原文 →NCT06385080NCT06385080按 - **标题 / Title：** A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer 对上
- **标题 / Title：** A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer读摘要原文 →NCT06437522NCT06437522按 - **标题 / Title：** A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors 对上
- **标题 / Title：** A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors读摘要原文 →NCT06629597NCT06629597按 - **标题 / Title：** A Phase III Study of YL201 in Recurrent or Metastatic Nasopharyngeal Carcinoma (TAISHAN-301) 对上
- **标题 / Title：** A Phase III Study of YL201 in Recurrent or Metastatic Nasopharyngeal Carcinoma (TAISHAN-301)读摘要原文 →NCT07276399NCT07276399按 - **标题 / Title：** A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer 对上
- **标题 / Title：** A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer读摘要原文 →来源：fangdisun · x.com